Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study
Authors:
- Xichen ZhangXZXichen Zhang
- John K. JacksonJJJohn K. Jackson
- Wesley WongWWWesley Wong
- Weixian MinWMWeixian Min
- Tony CruzTCTony Cruz
- William L. HunterWHWilliam L. Hunter
- Helen M. BurtHBHelen M. Burt
- 1 June 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 137 (2) , 199-208
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The role of hyaluronan in tumour neovascularization (review)International Journal of Cancer, 1995
- PaclitaxelDrugs, 1994
- Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release PropertiesJournal of Pharmacy and Pharmacology, 1994
- In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapyJournal of Biomedical Materials Research, 1994
- Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(l-lactic acid) or poly (l-lactic-co-glycolic acid) A-blocks attached to central poly ( oxyethylene ) B-blocksJournal of Controlled Release, 1993
- A new biodegradable copolymer of glycolic acid and lactones with relatively low molecular weight prepared by direct copolycondensation in the absence of catalystsJournal of Biomedical Materials Research, 1991
- Rapidly degraded terpolymers of DL‐lactide, glycolide, and ϵ‐caprolactone with increased hydrophilicity by copolymerization with polyethersJournal of Biomedical Materials Research, 1990
- Biodegradable PEO/PLA block copolymersJournal of Biomedical Materials Research, 1988
- Prolonged delivery of peptides by microcapsulesJournal of Controlled Release, 1987
- Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivoBiomaterials, 1981